Developed by Amgen, this next-generation therapy has generated major interest in the biotech and pharma worlds due to its potential for significant weight loss, convenient monthly dosing, and a unique design that blends peptide and antibody technologies
More than half of women with PCOS develop type 2 diabetes by the age of 40, according to the CDC, so Dunham thinks more people need to talk about how semaglutide may be able to help women with the condition
We champion a transparent, empathetic, and science-backed approach, from initial consultation and comprehensive lab work to personalized treatment plans and ongoing support
GLP-1 medications are life-changing for many people managing conditions like diabetes, obesity, heart disease, PCOS, and more
If youre curious whether oral supplements make sense for your situation, were happy to educate you and help you decide what fits your recovery plan